Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Study of SM-13496 in Bipolar I Disorder
NCT01986114Phase 3Completed
- Sponsor
- Sumitomo Pharma
- Start
- Jan 2014
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of lurasidone in bipolar I disorder, sponsored by Sumitomo Pharma. Started Jan 2014; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01986114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986114.